Abstract Background Tumor immune cell infiltrates are essential in hindering cancer progression and may complement the TNM classification. CD8+ and CD163+ cells have prognostic impact in breast cancer but their spatial heterogeneity has not been extensively explored in this type of cancer. Here, their potential as prognostic biomarkers was evaluated, depending on their combined densities in the tumor center (TC) and the tumor invasive margin (IM). Methods CD8+ and CD163+ cells were quantified by immunohistochemistry of formalin-fixed, paraffin-embedded (FFPE) tumor tissue samples from a cohort totaling 162 patients with histologically-confirmed primary invasive non-metastatic ductal breast cancer diagnosed between 2000 and 2015. Clinical fo...
BACKGROUND: The prognostic effect of tumor infiltrating CD8+ cytotoxic lymphocytes (CTLs) in breast ...
<div><p>Background</p><p>The prognostic effect of tumor infiltrating CD8<sup>+</sup> cytotoxic lymph...
PurposeTumor inflammatory response was evaluated as a prognostic feature in triple-negative breast c...
Background: Tumor-infiltrating lymphocytes are associated with a better prognosis in early triple-ne...
Background: Tumor associated macrophages (TAMs) are alternatively activated macrophages that enhance...
BACKGROUND: Tumor infiltrating lymphocytes (TILs) are widely considered a key sign of the immune int...
Introduction: Tumor infiltrating lymphocytes may indicate an immune response to can...
Background: Tumour-infiltrating lymphocytes (TILs) in breast cancer (BC) confer prognostic and predi...
BACKGROUND : Tumor-infiltrating lymphocytes are associated with a better prognosis in early triple-n...
Tumor-associated macrophages (TAMs) promote progression of breast cancer and other solid malignancie...
BACKGROUND: Tumor-infiltrating lymphocytes (TILs) have a strong prognostic value in various forms of...
Tumor-associated macrophages (TAMs) and abnormalities in cancer cells affect cancer progression and ...
Tumor-associated macrophages (TAMs) and abnormalities in cancer cells affect cancer progression and ...
The triple-negative subgroup of breast cancer (TNBC) (estrogen, progesterone-, and HER2-receptor ne...
Tumor-infiltrating lymphocytes (TILs) in breast cancer are a key representative of the tumor immune ...
BACKGROUND: The prognostic effect of tumor infiltrating CD8+ cytotoxic lymphocytes (CTLs) in breast ...
<div><p>Background</p><p>The prognostic effect of tumor infiltrating CD8<sup>+</sup> cytotoxic lymph...
PurposeTumor inflammatory response was evaluated as a prognostic feature in triple-negative breast c...
Background: Tumor-infiltrating lymphocytes are associated with a better prognosis in early triple-ne...
Background: Tumor associated macrophages (TAMs) are alternatively activated macrophages that enhance...
BACKGROUND: Tumor infiltrating lymphocytes (TILs) are widely considered a key sign of the immune int...
Introduction: Tumor infiltrating lymphocytes may indicate an immune response to can...
Background: Tumour-infiltrating lymphocytes (TILs) in breast cancer (BC) confer prognostic and predi...
BACKGROUND : Tumor-infiltrating lymphocytes are associated with a better prognosis in early triple-n...
Tumor-associated macrophages (TAMs) promote progression of breast cancer and other solid malignancie...
BACKGROUND: Tumor-infiltrating lymphocytes (TILs) have a strong prognostic value in various forms of...
Tumor-associated macrophages (TAMs) and abnormalities in cancer cells affect cancer progression and ...
Tumor-associated macrophages (TAMs) and abnormalities in cancer cells affect cancer progression and ...
The triple-negative subgroup of breast cancer (TNBC) (estrogen, progesterone-, and HER2-receptor ne...
Tumor-infiltrating lymphocytes (TILs) in breast cancer are a key representative of the tumor immune ...
BACKGROUND: The prognostic effect of tumor infiltrating CD8+ cytotoxic lymphocytes (CTLs) in breast ...
<div><p>Background</p><p>The prognostic effect of tumor infiltrating CD8<sup>+</sup> cytotoxic lymph...
PurposeTumor inflammatory response was evaluated as a prognostic feature in triple-negative breast c...